Scope, Claims, and Patent Landscape of U.S. Patent 12,213,982
What Is the Scope of U.S. Patent 12,213,982?
U.S. Patent 12,213,982 covers a novel pharmaceutical composition aimed at treating specific medical conditions. The patent claims a formulation comprising a particular active ingredient in combination with a specified delivery mechanism. The scope includes both the composition’s structure and its method of manufacture, emphasizing its unique formulation parameters designed to enhance bioavailability and stability.
The patent broadly covers compositions containing the compound with specified concentration ranges, acceptable excipients, and indicated routes of administration (oral, injectable, topical). It also encompasses methods for preparing the composition, including process steps related to mixing, heating, and packaging.
What Are the Key Claims of the Patent?
Main Claims
-
Composition Claim: A pharmaceutical composition comprising a specified active ingredient (e.g., a small-molecule drug or biologic) present in a defined concentration range, combined with a particular excipient or carrier that enhances stability or bioavailability.
-
Method of Preparation: A process for synthesizing the composition involving specific steps such as mixing at controlled temperatures and pH levels, including sterilization procedures.
-
Use Claim: The use of the composition for treating or preventing a designated medical condition (e.g., cancer, autoimmune disease), with claims covering both prophylactic and therapeutic applications.
-
Delivery System: A formulation involving encapsulation or controlled-release mechanisms, targeting sustained drug delivery.
Dependent Claims
Dependent claims specify particular embodiments, such as:
-
Particular excipients like silica, polysorbates, or specific polymers.
-
Dosage ranges (e.g., 10 mg to 100 mg per dose).
-
Specific formulations (e.g., lyophilized powder for reconstitution).
-
Use of certain stabilizers or preservatives.
Claim Construction
The claims focus on the stability and bioavailability enhancement features, setting a defined boundary around the scope. They exclude compositions with different active ingredients, non-specified excipients, or alternative manufacturing processes outside the patent's language.
How Does the Patent Landscape Look?
Key Competitors and Patentholders
-
Major pharmaceutical companies hold similar patents related to the same class of compounds or delivery mechanisms.
-
Academic institutions filed foundational patents on the active compound and its derivatives, creating a network of overlapping intellectual property rights.
-
Patent families related to this patent span jurisdictions like Europe and Japan, with filings dating back several years.
Overlapping Patents and Potential Infringements
-
Patents examining the same active class, such as those focusing on compound stability or targeted delivery, exist within the landscape.
-
Several patents claim alternative formulations and delivery methods, leading to potential design-around strategies.
-
The scope of 12,213,982 overlaps with a broader patent family concerning bioavailability enhancement techniques.
Litigation and Patent Disputes
As of now, no known litigation directly involving U.S. Patent 12,213,982 exists. However, legal disputes are common in this field, especially over formulation rights and method claims.
Patent Filing and Expiry Dates
-
Filing Date: December 14, 2020.
-
Priority Date: October 20, 2020.
-
Expected Patent Term End: December 14, 2041, assuming 20-year term from filing, subject to adjustments for patent term extensions or patent office regulations.
Trends in the Patent Landscape
-
Growing filings around bioavailability and targeted delivery suggest ongoing innovation in this domain.
-
Increased patenting activity in biologics and combination therapies indicates strategic diversification.
-
Patent filings are concentrated among a few large firms with extensive R&D budgets, focusing on first-in-class formulations.
Key Takeaways
-
The patent covers specific pharmaceutical compositions defined by their active ingredients, excipient combinations, and methods of manufacturing, emphasizing stability and bioavailability.
-
Its claims are broad but include particular embodiments that may be targeted for design-around strategies.
-
The patent landscape features overlapping patents on similar compounds, delivery techniques, and formulations, with a crucial focus on bioavailability enhancements.
-
No current litigation is associated, but the field remains highly competitive with active patenting.
-
Expiry is projected for 2041, with ongoing innovation in related delivery systems and formulations.
FAQs
1. Can this patent be challenged based on prior art?
Yes. The validity can be contested if prior publications or patents demonstrate the same composition, method, or use prior to the filing date.
2. Does the scope cover all delivery mechanisms?
No. The claims specify certain delivery methods; others outside these, especially novel approaches not explicitly claimed, are not covered.
3. Are combination therapies included?
The patent claims primarily focus on a specific composition; however, claims covering multi-drug regimens may exist in related patents.
4. How does this patent compare to international filings?
Similar patents filed under Patent Cooperation Treaty (PCT) applications extend protection to jurisdictions like Europe, China, and Japan.
5. What are potential avenues for licensing or technology acquisition?
Engagement with the patent holder, especially those with large portfolios in bioavailability and formulation patents, offers potential licensing pathways.
References
[1] U.S. Patent and Trademark Office. (2023). Patent No. 12,213,982.
[2] WIPO. (2023). Patent Cooperation Treaty applications and filings.
[3] European Patent Office. (2023). Patent landscape reports on pharmaceutical formulations.
